TNF-α suppresses IL-6 upregulation of protein S in HepG-2 hepatoma cells

Thrombosis Research

Volumn 81, Issue 3, 1996, Pages 315-326

  Hooper, W Craig ^a,b   Phillips, Donald J ^a   Evatt, Bruce L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HepG 2; IL 1; IL 6; Protein S; Thrombosis; TNF

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; INTERLEUKIN 6; ONCOSTATIN M; OSM PROTEIN, HUMAN; PEPTIDE; PROTEIN S; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; UPREGULATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CYTOKINES; HUMANS; INTERLEUKIN-6; LIVER; LIVER NEOPLASMS; ONCOSTATIN M; PEPTIDES; PROTEIN S; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0030087865     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00003-5     Document Type: Article

References (47)

1. GRIFFIN, J.H., EVATT, B.L., ZIMMERMAN, T.S., KLEIS, A.J. and WIDEMAN, C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370-1373, 1981.
2. COMP, P.C., NIXON, R.R., COOPER, M.R. and ESMON, C.T. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74, 2082-2088, 1984.
3. SCHWARTZ, H.P., FISCHER, M, HOPMEIER, P., BATARD, M.A. and GRIFFIN, J.H., Plasma protein S deficiency in familial thrombotic disease. Blood 64, 1297-1300, 1984.
4. ENGESSER, L., BROEKMANS, A.W., BRIET, E., BROMMER, E.J. and BERTINA, R.M. Hereditary protein S deficiency: Clinical manifestations. Ann Int Med 106, 677-682, 1987.
5. VIGANO-D'ANGELO, S., D'ANGELO, A., KAUFMAN, C.E. Jr, SHOLER, C., ESMON, C.T. and COMP, P.C. Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med 107, 42-47, 1987.
6. D'ANGELO, A., VIGANO-D'ANGELO, S., ESMON, C.T. and COMP, P.C. Acquired deficiencies of protein S: Protein S activity during oral anticoagulation, in liver disease and in disseminated intravascular coagulation. J Clin Invest 81, 1445-1454, 1988.
7. MALM, J., LAURELL, M. and DAHLBÄCK, B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 68, 437-443, 1988.
8. RUIZ-ARGUELLES, G.J., RUIZ-ARGUELLES, A., DELEZE, M. and ALARCON-SEGOVIA, D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. J of Rheumatology 16, 381-383, 1989.
9. GEARSON, W.T., DICKERMAN, J.D., BOVILL, E.G. and GOLDEN, E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 91, 418-1422, 1993.
10. STAHL, C.P., WIDEMAN, C.S., SPIRA, T.J., HAFF, E.G., HIXON, G.J. and EVATT, B.L. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood. 81, 1801-1807, 1993.
11. TAYLOR, F.B. Jr., CHANG, A., ESMON, C.T., D'ANGELO, A., VIGANO-D'ANGELO, S. and BLICK, C. E. Protein C prevents the coagulopathic and lethal effect of E. coli infusion in the baboon. J Clin Invest 79, 918-925, 1987.
12. HEEB, M.J., MOSHER, D. and GRIFFIN, J.H. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 73, 455-461, 1989.
13. KOGAN, A.E. and STRUKOVA, S. M. Protein C decreases in experimental DIC in rats. Thromb Research 57, 825-826, 1990.
14. OKAJIMA, K., IMAMURA, H., KOGA, S., INOUE, M., TAKATSUKI, K. and AOKI, N. Treatment of patients with disseminated intravascular coagulation by protein C. Am J Hematol 33, 277-278, 1990.
15. TAYLOR, F., CHANG, A., FERRELL, G., MATHER, T., CATLETT, R., BLICK, K. and ESMON, C.T. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 78, 357-363, 1991.
16. FOURRIER, F., CHOPIN, C., GOUDEMAND, J., HENDRYCX, S., CARON, C., RIME, A., MAREY, A. and LESTAVEL, P. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest. 101, 816-823, 1992.
17. van der POLL, T., LEVI, M., HACK, C.E., ten Cate, H., van DEVENTER, S.J.H., EERENBERG, A.J.M., de GROOT, E.R., JANSEN, J., GALLANTI, H., BÜLLER, H.R., ten Cate, J.W. and AARDEN, L.A. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179, 1253-1259, 1994.
18. ESMON, C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264, 4743-4746, 1989.
19. KISIEL, W., CANFIELD, W.M., ERICSSON, L.H. and DAVIE, E.W. Anticoagulant properties of bovine protein C following activation by thrombin. Biochemistry 16, 5824-5831, 1977.
20. WALKER, F.J., SEXTON, P.W. and ESMON, C.T. The inhibition of blood coagulation by activated protein C through selective inactivation of activated Factor V. Biochim Biophys Acta 571, 333-342, 1979.
21. WALKER, F.J. Regulation of activated protein C by protein S. J Biol Chem 256, 11128-11131, 1981.
22. ESMON, N.L., OWEN, W.G. and ESMON, C.T. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257, 859-864, 1982.
23. DAHLBÁCK, B. and STENFOLO, J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 78, 2512-2516, 1981.
24. DAHLBÄCK, B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 261, 12022-12027, 1986.
25. DAHLBÄCK, B., Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 66, 49-61, 1991.
26. BEVILACQUA, M.P., POBER, J.S., MAJEAU, G.R., FIERS, W., COTRAN, R.S. and GIMBRONE, M.A. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Nat Acad Sci USA 83, 4533-4537, 1986.
27. NAWROTH, P.P. and STERN, D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163, 740-745, 1986.
28. BEUTLER, B. and CERAMI, A. Cachectin. more than a tumor necrosis factor. N Engl J Med 316, 379-385, 1988.
29. WAAGE, A., BRANDTZAEG, P., HALSTENSEN, A., KIERULF, P. and ESPEVIK, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp Med. 169, 333-338, 1989.
30. van DEVENTER, S.J.H., BULLER, H.R., ten CATE, J.W., AARDEN, L.A., HACK, C.E. and STURK, A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76, 2520-2526, 1990.
31. van der POLL, T., BÜLLER, H.A., ten CATE, H., WORTEL, C.H., BAUER, K.A., van DEVENTER, S.J.H., HACK, C.E., SAUERWEIN, H.P., ROSENBERG, R.D. and ten CATE, J.W. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Eng J Med 322, 1622-1627, 1990.
32. CONWAY, E.M. and ROSENBERG, R.D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Bio 8, 5588-5592, 1988.
33. SCARPATI, E.M. and SADLER, J.E. Regulation of endothelial cell coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264, 20705-20713, 1989. Addendum 265, 14696, 1990.
34. TRACEY, K.J., BEUTLER, B., LOWRY, S.F., MERRYWEATHER, J., WOLPE, S., MILSARK, I.W., HARIRI, R.J., FAHEY III, T.J., ZENTELLA, A., ALBERT, J.D., SHIRER, G.T. and CERAMI, A. Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474, 1986.
35. SEHGAL, P.B., GRIENINGER, G. and TOSATO, G. Regulation of the Acute phase and Immune responses:Interleukin-6. Ann. New York Acad. Sci. 557-583, 1989.
36. HEINRICH, P.C., CASTELL, J.V. and ANDUS, R. Interleukin-6 and the acute phase response. Biochem J 265, 621-636, 1990.
37. GAULDIE, J, GEISTERFER, M., RICHARDS, C. and BAUMANN, H. IL-6 regulation of the hepatic acute phase response. In IL-6: Physiopathology and Clinical Potential. M. Revel, editor. Raven Press 88, 151-162, 1992.
38. KUSHNER, I. The role of IL-6 in regulation of the acute phase response. In IL-6: Physiopathology and Clinical Potential. M. Revel, ed. Raven Press 88, 163-171, 1992.
39. TAYLOR, F.B., Jr., CHANG, A., RUF, W., MORRISSEY, J.H., HINSHAW, L., CATLETT, R., BLICK, K. and EDGINGTON, T.S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33, 127-134, 1991.
40. HOOPER, W.C., PHILLIPS, D.J., RIBEIRO, M., BENSON, J. and EVATT, B.L. IL-6 upregulates protein S expression in the HepG-2 hepatoma cell line. Thromb Haemost 73, 819-824, 1995.
41. PHILLIPS, D.J., EVATT, B.L. and HOOPER, W.C. Development of an ELISA for quantification of human protein S in cell culture fluids using commercial polyclonal antisera. J Immunoassay 15, 411-428, 1994.
42. HOOPER, W.C., PHILLIPS, D.J., RIBERIO, M.J.A., BENSON, J.M., GEORGE, V.G., ADES, E.W. and EVATT, B.L. Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood. 84, 483-489, 1994.
43. HACK, C.E., de GROOT, E.R., FELT-BERSMA, R.J.F., NUIJENS, J.H., STRACK van SCHIJNDEL, R.J.M., EERENBERG-BELMER, A.J.M., THUS, L.G. and AARDEN, L.A. Increased plasma levels of interleukin-6 in sepsis. Blood 74, 1704-1710, 1989.
44. COMP, P.C., DORAY, D., PATTON, D. and ESMON, C.T. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 67, 504-508, 1986.
45. YAP, S.H., MOSHAGE, H.J., HAZENBERG, B.P.C., ROELOFS, H.M.J., BIJZET, J., LIMBURG, P.C., AARDEM, L.A. and van RIJSWIJK, M.H. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochimica et Biophysica Acta 1091, 405-408, 1991.
46. MACKIEWICZ, A., SPEROFF, T., GANAPATHI, M.K. and KUSHNER, I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146, 3032-3027, 1991.
47. RICHARDS, C.D., BROWN, T.J., SHOGAB, M., BAUMANN, H. and GAULDIE, J. Recombinant oncostatin M stimulates the products of acute phase proteins in HepG-2 cells and rat primary hepatocytes in vitro. J Immunol 148, 1731-1736, 1992.